This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

WEB REGISTRATION CLOSES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center
Book Now
Menu
Book Now

Jane Wang, Ph.D.
Executive Director of Delivery Technologies at Tessera Therapeutics
Speaker

Profile

Jane joined the Tessera team in 2021 and is currently Executive Director, Head of Delivery Technologies. Prior to joining Tessera, she was technical lead of the nanoparticle program at Verily Life Sciences, where she worked on a variety of delivery technologies including LNP barcoding and extrahepatic nanoparticle delivery. Her background is in drug delivery, chemistry and enzyme engineering and she holds a PhD in Chemistry from UC Berkeley and a BS from the California Institute of Technology in Chemistry.

Agenda Sessions

  • Delivery of RNA Gene Writing Systems to Liver and Beyond

    , 9:00am
    View Session

At this event

Prev
Next
Jonathan Watts, PhD
Associate Professor, RNA Therapeutics Institute
University of Massachusetts Medical School

See Jane at TIDES USA: Oligonucleotide & Peptide Therapeutics

Book Now